Press Release
- Services
- Press Release
Zydus Lifesciences Limited announced an extension in the timeline for completing the acquisition of the Active Pharmaceutical Ingredient (API) business of Sterling Biotech Limited, reinforcing its strategy to strengthen API
TopGum Industries Ltd. announced the signing of a binding Letter of Intent (LOI) to acquire U.S.-based manufacturing operations, marking its strategic entry into the pharmaceutical sector. The development, announced on
Scinai Immunotherapeutics Ltd. announced the completion of its acquisition of Recipharm Israel Ltd., marking a strategic expansion into Active Pharmaceutical Ingredient (API) development and manufacturing. The development, announced on April
Scinai Immunotherapeutics Ltd. highlighted its expanded contract development and manufacturing (CDMO) platform and immunology pipeline during BIO-Europe Spring 2026. The update, shared on March 18, 2026, reflects the company’s strategic
RPG Life Sciences Limited outlined its long-term growth strategy, which includes expanding its presence in the Active Pharmaceutical Ingredient (API) segment through potential acquisitions. The development highlights the company’s intent
Recipharm announced the divestment of its API development and manufacturing facility in Israel to Scinai Immunotherapeutics Ltd., as part of its ongoing strategic transformation. The development, announced on February 16,
The global pharmaceutical industry is witnessing a surge in strategic partnerships and acquisitions as companies strengthen their pipelines and invest in next-generation therapeutics. According to a roundup published on February
How can we help you?
Reach out to discuss how our team can help your business achieve real results.
- Why Choose us?
- Experienced Experts with Diverse Industry Backgrounds.
- A record of delivering insightful and actionable recommendations.
- Tailored methodologies to address the client's unique requirements.
- End-to-End Services - market analysis, consumer behaviour, competitive intelligence, and strategic recommendations.
- Advanced tools and technology are used to produce insightful and comprehensive reports.
- Global research capability backed by a network of subject-matter experts and regional partners.
- In-depth knowledge of international markets, regulations, and trends.
- Work closely with the client to identify their specific needs and deliver custom insights.
- Value-focused through efficient and high-quality research outcomes.
